Chemotherapy-Induced Cardiotoxicity in Adolescent After Heart Transplant: Do Not Forget the Right Ventricle

Pediatric Cardiology
Diana Salas-MeraFederico Gutiérrez-Larraya

Abstract

The evaluation of oncologic patients at risk of chemotherapy-induced cardiotoxicity usually focuses on left ventricular function. However, recent studies have demonstrated that right ventricle impairment often coexists (and in some cases precedes) left-side affectation. We present the case of a 19-year-old heart transplant recipient who developed severe right ventricular dysfunction secondary to treatment of an abdominal lymphoma.

References

Sep 25, 2008·Journal of the National Cancer Institute·Ann C MertensYutaka Yasui
Mar 26, 2009·Journal of the National Cancer Institute·Nadia HowladerBrenda K Edwards
Feb 27, 2016·European Heart Journal Cardiovascular Imaging·Jon R ChristiansenSvend Aakhus
Mar 31, 2016·European Heart Journal Cardiovascular Imaging·Jutta Bergler-Klein
Jul 28, 2016·Echo Research and Practice·Kevin E BoczarGirish Dwivedi

❮ Previous
Next ❯

Citations

May 31, 2020·Journal of Cardiovascular Translational Research·Rafey A FerozeSalim S Hayek

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.